Basic Information
SNIPR Biome is an exploratory-stage biotechnology company aimed at revolutionizing the treatment of microbiome-related diseases. SNIPR Biome's goal is to develop CRISPR-based medicines for more effective and safer treatment of difficult-to-treat infectious diseases in the future, as well as to produce therapeutic agents in situ within the human microbiome.
SNIPR Biome ApS
Denmark
15~50 people
January 01, 2015
contact@sniprbiome.com

